Experimental Pathology, Malmö
21 – 30 of 169
                - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
        Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2023
- 
                        Mark
        Implications of antibiotics and antimicrobial resistance development during COVID-19 : questing genomic surveillance for a balancing act
    (2023) p.375-395- Chapter in Book/Report/Conference proceeding › Book chapter
 
- 
                        Mark
        Natural flavonoids exhibit potent anticancer activity by targeting microRNAs in cancer : A signature step hinting towards clinical perfection
    
    - Contribution to journal › Article
 
- 2022
- 
                        Mark
        Computational Evidence Based Perspective on the Plausible Repositioning of Fluoroquinolones for COVID-19 Treatment
    
    - Contribution to journal › Article
 
- 
                        Mark
        Increased MARCKS Activity in BRAF Inhibitor-Resistant Melanoma Cells Is Essential for Their Enhanced Metastatic Behavior Independent of Elevated WNT5A and IL-6 Signaling
    
    - Contribution to journal › Article
 
- 2021
- 
                        Mark
        Targeting Oncogenic WNT Signalling with WNT Signalling-Derived Peptides
    
    - Chapter in Book/Report/Conference proceeding › Book chapter
 
- 
                        Mark
        A review emphasizing on utility of heptad repeat sequence as a tool to design pharmacologically safe peptide-based antibiotics
    
    - Contribution to journal › Scientific review
 
- 
                        Mark
        Reduced WNT5A signaling in melanoma cells favors an amoeboid mode of invasion
    
    - Contribution to journal › Article
 
- 
                        Mark
        Translational research in drug discovery : Tiny steps before the giant leap
    (2021) p.347-369- Chapter in Book/Report/Conference proceeding › Book chapter
 
- 2020
- 
                        Mark
        WNT5A-induced activation of the protein kinase C substrate MARCKS is required for melanoma cell invasion
    
    - Contribution to journal › Article
 
- 2019
- 
                        Mark
        Combination therapy targeting the elevated interleukin-6 level reduces invasive migration of BRAF inhibitor-resistant melanoma cells
    
    - Contribution to journal › Article
 
